90 search results for: patient burden

Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?
expert video

Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?

Rhinology
Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.
View more
How Should We Define and Classify Prurigo Nodularis?
expert video

How Should We Define and Classify Prurigo Nodularis?

Dermatology
Dr. Sarina Elmariah explains how to recognize and classify PN, using clinical examples and comparisons with related conditions. She then discusses PN assessment in clinical studies and practice, and the unmet needs in disease understanding and diagnosis.
View more
Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline
videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

Pulmonology
Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.
View more
ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?
expert video

ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?

Pulmonology
Dr. Francesca Puggioni presents the latest clinical data on achieving on-treatment remission with biologics.
View more
ERS 2023 | Advancing Asthma Management Beyond Control
expert video

ERS 2023 | Advancing Asthma Management Beyond Control

Pulmonology
Prof. Ian Pavord discusses the current proposed framework for clinical remission in severe asthma.
View more
New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management
expert video

New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management

Dermatology
Review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region